PAHC (STOCKS)
Phibro Animal Health Corporation Class A
$32.380000
+0.850000 (+2.70%)
Prev close: $31.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jack C. Bendheim
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,310.24M
- Employees
- 2,475
- P/E (TTM)
- 13.54
- P/B (TTM)
- 3.53
- Dividend Yield
- 152.24%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q3)
|
$0.76 | $0.73 | +0.0327 | +4.50% |
|
Dec 2025 (Q2)
|
$0.87 | $0.68 | +0.1866 | +27.30% |
|
Sep 2025 (Q1)
|
$0.73 | $0.64 | +0.0950 | +14.96% |
|
Jun 2025 (Q4)
|
$0.57 | $0.53 | +0.0396 | +7.47% |
Financial Statements
| Revenues | $1.50B |
| Benefits Costs and Expenses | $1.37B |
| Cost Of Revenue | $1.01B |
| Costs And Expenses | $1.37B |
| Gross Profit | $488.12M |
| Operating Expenses | $308.17M |
| Selling, General, and Administrative Expenses | $308.17M |
| Operating Income/Loss | $179.96M |
| Income/Loss From Continuing Operations After Tax | $95.23M |
| Income/Loss From Continuing Operations Before Tax | $128.85M |
| Income Tax Expense/Benefit | $33.62M |
| Net Income/Loss | $95.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $95.23M |
| Net Income/Loss Available To Common Stockholders, Basic | $95.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.34 |
| Diluted Earnings Per Share | $2.34 |
| Basic Average Shares | 81,091,000 |
| Diluted Average Shares | 81,962,000 |
| Assets | $1.45B |
| Current Assets | $894.07M |
| Inventory | $539.70M |
| Other Current Assets | $354.37M |
| Noncurrent Assets | $551.05M |
| Fixed Assets | $359.27M |
| Other Non-current Assets | $191.78M |
| Liabilities | $1.08B |
| Current Liabilities | $281.87M |
| Accounts Payable | $129.64M |
| Wages | $50.74M |
| Other Current Liabilities | $101.49M |
| Noncurrent Liabilities | $801.42M |
| Long-term Debt | $620.52M |
| Other Non-current Liabilities | $180.91M |
| Equity | $361.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $361.83M |
| Liabilities And Equity | $1.45B |
| Net Cash Flow From Operating Activities | $66.13M |
| Net Cash Flow From Operating Activities, Continuing | $66.13M |
| Net Cash Flow From Investing Activities | -$62.04M |
| Net Cash Flow From Investing Activities, Continuing | -$62.04M |
| Net Cash Flow From Financing Activities | -$12.71M |
| Net Cash Flow From Financing Activities, Continuing | -$12.71M |
| Exchange Gains/Losses | $3.19M |
| Net Cash Flow | -$5.43M |
| Net Cash Flow, Continuing | -$8.62M |
| Comprehensive Income/Loss | $113.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $113.93M |
| Other Comprehensive Income/Loss | $42.72M |
| Other Comprehensive Income/Loss Attributable To Parent | $18.70M |